CD86 and neoplasm: Additionally, eCPMV treatment also resulted in significant influx of the CD11b+Ly6G+MHCII+CD86+ tumor infiltrating neutrophils (TINs) that also displayed high expression levels of CD86 and MHCII molecules (Figure 3B).